Skip to content

PET molecular imaging in the dopamine receptor study of adolescent patients with Tourette Syndrome

PET molecular imaging in the dopamine receptor study of adolescent patients with Tourette Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-15007425
Enrollment
Unknown
Registered
2015-11-19
Start date
2015-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tourette syndrome

Interventions

Gold Standard:
Index test:

Sponsors

Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
11 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Patients with TS: (1) age between 18 to 25 years; (2) History meet the criterion of American Diagnostic and Statistical Manual of Mental Disorders fourth Edition ( DSM-IV-TR ); (3) A total of 20 patients (Men and women each have 10 people); 2. Healthy volunteers (The data have been acquired in previous clinical study, which was proved by ethical review and recorded in Chinese Clinical Trial Registry. Registration number: ChiCTR-OCC-09000358): Men and women each have 5 people; 3. No history of physical, especially brain organic disease, and no history of substance use including analgesics, antiepileptics and antipsychotic. Patients of TS do not have other disease; 4. No other serious concomitant diseases; 5. Willing and able to follow the program during the study period; 6. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. History of allergies to Contrast agents or tracers; 2. Having received any experimental drugs or protocols in half a year before entering the group , that is, having participated in another experiment; 3. Current or past use of addictive drugs, analgesics, antiepileptics and antipsychotic; 4. Current or planned pregnancy; 5. Subjects receivied major surgery within 1 year before entering the group, or not yet fully recovered from the effects of major surgery; 6. Claustrophobic patients 7. Unwilling and unable to follow the program during the study period; 8. Current or past mood disorder, anxiety disorder, psychotic disorder, or mental retardation based on DSM-IV criteria.

Design outcomes

Primary

MeasureTime frame
Function of dopamine receptor;Function of 5-HT receptor;

Countries

China

Contacts

Public ContactJianhua Feng
zyk112000@gmail.com+86 17858610213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026